Purpose: This study was designed to evaluate the comparison between the subjective and the objective evaluation of pain control effect in masticatory muscle pain depending on time and dose change.
INTRODUCTION
Pain is a more or less localized sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings by the medical dictionary definition.
1) It serves as a protective mechanism insofar as it induces the sufferer to remove or withdraw from the source. And pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage by the International Association for the Study of Pain (IASP) definition of pain.
2)
The subjective experience of pain arises by four distinct processes which consist of transduction, transmission, modulation and perception. 3) Transduction is the process by which noxious stimuli lead to electrical activity in the appropriate sensory nerve endings. Transmission refers to the neural events that carry the nociceptive input into the Central Nervous System (CNS) for proper processing.
Modulation refers to the ability of the CNS to control the pain-transmitting neurons. And if nociceptive input reaches the cortex, perception occurs; this immediately initiates a complex interaction among neurons in the higher center of the brain.
Four terms related with pain-nociception, pain, suffering, and pain behavior-are differently used. The patient subjectively feels and objectively expresses pain. Difference between the subjective and the objective pain evaluations generally exists. It therefore makes clinicians difficult to exactly select and decide contents, duration and the final goal of treatment. Such difference also can be varied even depending on the duration of pain control, types of drug and dose change.
This study was designed to evaluate the comparison between the subjective and the objective evaluation of pain control in masticatory muscle pain with time and by dose change.
MATERIALS AND METHODS
Subjects
The subjects participated in this study were volunteers The subjects who had systemic musculoskeletal pain, systemic arthritis, malignant tumor, hypertension, diabetes mellitus, and cardiovascular disease were excluded.
Pregnant women and chronic analgesic or psychiatric drug users were also excluded.
Methods
One researcher randomly divided the subjects into three groups with 10 people each who had diagnosed according to the RDC/TMD. Another researcher injected 0.2 mL drug with 27 G subcutaneous needle and 1.0 mL disposable syringe (Sofjec; Hwajin Medical, Cheonan, Korea) into each subject for 10 seconds, and injection point was the most painful area on unilateral masticatory muscle in palpation.
The other researcher randomly ordered the sequence of injected drugs. As a result, double blind procedure about the injected drug was performed by both researchers and subjects.
Initially classified subject groups were morphine sulfate (15 mg/1 mL; BC World Pharm, Seoul, Korea) 3.0 mg injection group (n=10), morphine sulfate (15 mg/1 mL; BC World Pharm) 1.5 mg injection group (n=10), and saline (NaCl 9 mg/1 mL; JW Pharmaceutical, Seoul, Korea) injection group (n=10).
Each group was evaluated for both subjective and objective pain at just before the injection, 10 minutes, 30 minutes, 1 hour, 24 hours, and 48 hours after the injection.
Pain Evaluation

1) Subjective pain evaluation
The methods used to evaluate the subjective pain in this study were VAS and McGill pain questionnaire (MPQ) test.
For the VAS test, subjects were asked to mark their pain with marking pen (namepen; Monami, Yongin, Korea) on 100 mm straight line according to pain extent; start point of 100 mm straight line with no pain, end point with the strongest pain that they could imagine. The result was converted into numbers according to the percentage.
For the MPQ method, the MPQ in Korean version was 
2) Objective pain evaluation
The methods used to evaluate the objective pain were pressure pain threshold (PPT) test and pressure pain toler-
The PPT test used in this study was to estimate the PPT around the most painful masticatory area before and after the injection with the pressure pain measuring instrument (Wagner Instruments, Greenwich, CT, USA), and then the estimation of pressure pain was converted into number.
The PTO was applied to the same area and used the same pressure pain measuring instrument to calculate the pain limit of same pressure, and its estimation was also converted into number.
We kept the patient's masticatory system as relaxed position as possible without tooth contact to use the pressure pain measuring instrument. The pressure was applied to muscle vertically with 11 mm diameter probe with 30 kPa/s velocity; the measured kgf value was divided by area of the probe and converted to kPa value. The subjects were asked to raise their left hand at the moment that they felt the first pain and intolerable pain, and then the values were recorded and calculated for the PPT and the PTO.
Statistical Analysis
The results from two subjective pain evaluation tests and two objective pain evaluation tests were analyzed by the repeated measures ANOVA (analysis of variance) test using descriptive statistics and Greenhouse-Geisser method for the short-term pain evaluation and one-way ANOVA test and Dunnett's multiple comparison test for the long-term objective pain evaluation. At first, we verified the effects; within subject effects, between subject effects and interaction effects. When there were effects, we tried post hoc through multiple comparisons using Tukey HSD (honestly significant differences) method.
All the statistics significance level were p<0.05 and study scores were analyzed with PASW Statistics version 18.0 (IBM Co., Armonk, NY, USA).
RESULTS
Short-term Pain Evaluation
The p-value summary of post hoc multiple comparisons by Tukey HSD in the short-term subjective pain evaluation and the objective pain evaluation was in Table 1 . VAS (p<0.001) and MPQ (p<0.001) in the short-term subjective pain evaluation were significantly different and PPT (p<0.001) and PTO (p<0.001) in the short-term objective pain evaluation were significantly different.
Therefore, the difference between the subjective pain evaluation and the objective pain evaluation were no statistically significant in the short-term pain evaluation with time.
Long-Term Subjective Pain Evaluation
The mean data of VAS (%) for morphine 3.0 mg injection group in the long-term subjective pain evaluation were shown in Fig. 1A . Those for morphine 1.5 mg injection group in the long-term subjective pain evaluation were in The p-value summary by one-way ANOVA test and Dunnett's multiple comparison test in the long term subjective pain evaluation was in Table 2 . were more significantly different than 24 hours after the injection (p<0.01) in the morphine 3.0 mg injection group.
Long-Term Objective Pain Evaluation
The mean data of PPT (%) for morphine 3.0 mg injection group in the long-term objective pain evaluation were The p-value summary by one-way ANOVA test and Dunnett's multiple comparison test in the long-term objective pain evaluation were in Table 3 .
The morphine 1.5 mg injection group was more significantly different than the morphine 3.0 mg injection group in 1 hour (p<0.01), 24 hours (p<0.01), and 48 hours (p<0.01)
in PPT. The morphine 1.5 mg injection group was more significantly different than the morphine 3.0 mg injection group in 1 hour (p<0.05) in PTO. joint (TMJ) to reduce pain. 13) The study of Chun et al., 14) which was about the influence of terminal AMPA receptor to the muscle nociception and c-fos activation, proposed that GluR1 and GluR2, the AMPA receptor subunits, were developed in the trigeminal ganglion neurons and masseter afferent nerve cell bodies. As a result, acute muscle pain is partially mediated by AMPA receptors located in the terminal, and when several terminal glutamate receptor subunits are blocked it might reduce the muscle pain and central nerve activation more effectively.
In the study of Ro et al., 15) the animal model of hypertonic saline (HS) infusion protocol causes peripheral release of glutamate, and that blockade of peripheral NMDA receptors significantly reduces HS-induced nociceptive behavior and central neuronal activation.
Chun and Ro 16) suggested that intramuscular capsaicin in rat masseter muscle significantly induced increase of trigeminal caudalis (Vc) neuron response and that the blockade of peripherally localized mGluR5 could effectively attenuate muscular hypersensitivity.
The study of Yoo et al. 17) was to evaluate the pain control by morphine injection to patient's masticatory muscle. For this study, patients with masticatory muscle pain were recruited and diagnosed according to the RDC/TMD.
Experimental group were divided into three groups; saline injection group (n=10), lidocaine injection group (n=10), and morphine injection group (n=10). Evaluation list was the subjective pain evaluation (VAS, MPQ, and pain drawing) and the objective pain evaluation (PPT and PTO) and evaluation time were 0, 10, 30, 60 minutes after injection, and then data were statistically analyzed. In this study, the subjective pain evaluation and the objective pain evaluation were significantly different within group (p<0.001). The subjective pain drawing evaluation (p<0.001) were significantly different between groups. The objective PPT evaluation (p=0.025) were significantly different between groups.
The morphine injection group (p=0.001) were more significantly different than the saline injection group in the pain Therefore, it was revealed that the morphine 3 mg injection was effective to control masticatory muscle pain within 48 hours and more effective than lidocaine injection.
The study of Bae et al. 19) was to evaluate the sex differences 26) trigeminal neuralgia and atypical facial pain: use of the MPQ for discrimination and diagnosis by Melzack et al., 27) the MPQ from description to measurement by Melzack, 28) TMJ disorders and myogenic facial pain: a discriminative analysis using the MPQ by Mongini and Italiano. 29) In the study of PPT by Melia et al., 30) pain thresholds are widely used in behavioral research, but unlike other pain modalities, a standardized assessment of pressure pain remains a challenge. In this research, they described the application of an automatic pressure algometer with a linear increase in force. Ergonomically designed fixation devices were developed to increase the accuracy and to shorten the time of each measurement. Ten healthy volunteers were included in a pilot study to test the algometry method. PPT were investigated over 2 experimental days in three nonconsecutive runs at 29 measurement sites. During the experiment, subjects reported their subjective sleepiness, level of state-anxiety, psychological status and the perceived PI of each measurement. PI ratings indicate that instructions were followed. State-anxiety and subjective sleepiness levels were low throughout the experiment. The method has proven to be suitable for standardized PPT measurements across the body in an ergonomic, safe, and user-friendly fashion.
There are study of PPT effect, palpation and PPT: reliability and validity in patients with TMD by Gomes et al., 31) PPT in the detection of masticatory myofascial pain: an algometer-based study by Santos Silva et al., 32) PPT, clinical assessment and differential diagnosis: reliability and validity in patients with myogenic pain by Ohrbach and Gale, 33) and the Influence of myofascial temporomandibular disorder pain on the PPT of women during a migraine attack by Pinto Fiamengui et al. 34) In the study of PTO by Chesterton et al., 35) 
